Rheumatoid Arthritis Clinical Trials in New York

Showing 3481-3500 of 3,596 trials

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

NCT00014651

RATIONALE: Drugs such as vapreotide may prevent complications following pancreatic resection. It is not yet known if vapreotide is more effective than no further therapy in preventing side effects of pancreatic resection. PURPOSE: This randomized phase III trial is studying vapreotide to see how well it works compared to a placebo in preventing complications in patients undergoing surgery for pancreatic cancer.

Pancreatic CancerPerioperative/Postoperative Complications

Mayo ClinicStarted Mar 2001

Birmingham, Alabama, United States • Tampa, Florida, United States • Chicago, Illinois, United States +15 more locations

COMPLETEDPhase 4< 1 mile

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

NCT00118742

This two-arm study will assess the efficacy and safety of a long-term calcineurin inhibitor-free maintenance regimen with CellCept and sirolimus in recipients of an orthotropic liver transplant. Patients will be randomized to receive either CellCept 1-1.5 g twice daily (BID) + tacrolimus + cyclosporine, or CellCept 1-1.5 g BID + sirolimus. The anticipated time on study treatment is 1 to 2 years, and the target sample size is 100 to 500 individuals.

Liver Transplantation

Hoffmann-La Roche293 participantsStarted Aug 2005

Birmingham, Alabama, United States • Phoenix, Arizona, United States • La Jolla, California, United States +43 more locations

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Rheumatoid Arthritis Trials in Other Cities

Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy

Treatment of Polycythemia Vera With Gleevec

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

A Trial of Skin Care Protocols for Facial Resurfacing

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Herpetic Eye Disease Study (HEDS) II

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease

Validation of an Obstacle Course Used in Patients With Muscle Tightness

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD

Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

Pilot Study Assessing the Feasibility of Treating Foot Drop With the Neurostep™ System.

Other Conditions in New York